baber/WOPTO huggingface dataset:
Patent NZ-334675-A (NZ)
Title: Method and apparatus for using image analysis to determine meat and carcass characteristics
Inventor: TONG ALAN KWAI-WAH
IPC: G06T7/40
Filed: 1997-08-18
Abstract: Apparatus 20 for determining a quality grade of an animal carcass 16 comprises:  (a) image acquisition means for obtaining an image which includes the rib eye of the carcass; (b) computing and storage means 26 and (c) means for providing an output of the quality grade of the carcass. The computing and storage means: (i) stores the image as an array of pixels providing colour data representative of colour information at the corresponding part of the image; (ii) discriminates pixels representing muscle tissue from pixels representing fat tissue on the basis of a pixel colour characteristic threshold; (iii) identifies a cluster of muscle tissue pixels within the image that represents the rib eye muscle and traces the outline of the rib eye muscle to exclude external image sections representing muscle tissue which abuts but is not part of the rib eye; (iv) determines the proportion of pixels within the rib eye outline representing fat relative to the total number of pixels within the rib eye outline to obtain a value of the percentage of intramuscular fat in the rib eye; (v) applies means (i) through (iv) to a plurality of reference images of rib eyes of carcasses of predetermined quality grade to establish a relationship between the percentage of intramuscular fat in the rib eye and the quality grade of the carcass; (vi)	solves the relationship determined by means of (v) for the value of the percentage of intramuscular fat in the rib eye determined by means of (iv) to determine the quality grade of the carcass.
Patent NZ-335581-A (NZ)
Title: Graft copolymerized compositions comprising unsaturated olefin and carbon monoxide monomers, use as a wood adhesive
Inventor: ASH CARLTON EDWIN
IPC: C09J151/08
Filed: 1997-12-18
Abstract: elatively low molecular weight olefin/CO polymers eg., ethene and propene are graft copolymerized. The graft copolymers provide the basis for waterborne adhesives that are particularly useful for making wood composites.  Also claimed is the method for making a curable resin comprising dispersing an alternating aliphatic polymer of olefinically unsaturated compounds and carbon monoxide, and either adding an initiator and monomer to said dispersion to form a graft copolymer, or adding a vinyl monomer and exposing the combination of the alternating aliphatic polymer of olefinically unsaturated compounds and carbon monoxide and the vinyl monomer to high energy radiation to form a graft copolymer.
Patent NZ-337612-A (NZ)
Title: Breast stabilization device for imaging and invasive procedures with breast contacting member conforming to breast shape and imaging port
Inventor: LEE ROBERTA
IPC: A61B8/08
Filed: 1999-09-03
Abstract: A breast stabilizing device for imaging and invasive procedures is disclosed, having a breast contacting member closely surrounding the breast, and an imaging port 150 allowing the breast to be imaged.
Patent NZ-502209-A (NZ)
Title: Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
Inventor: BOSMANS JEAN-PAUL RENE MARIE A
IPC: A61P1/14
Filed: 1998-07-07
Abstract: Compounds of formula (I), a stereochemically isomeric forms thereof, an N-oxide form thereof or a pharmaceutically acceptable acid addition salt thereof, wherein R1 and R2 taken together form a bivalent radical wherein in said bivalent radical one or two hydrogen atoms may be substituted with C1-6alkyl, R3 is hydrogen or halo, R4 is hydrogen or C1-6 alkyl, R5 is hydrogen or C1-6 alkyl, L is C3-6 cycloalkyl, C5-6 cycloalkanone, C2-6 alkenyl, or L is a radical of formula Alk-R6, Alk-X-R7, Alk-Y-C(=O)-R9, or Alk-Y-C(=O)-NR11R12 wherein each Alk is C1-12 alkanediyl, R6 is hydrogen, cyano, C1-6 alkylsulfonylamino, C3-6 cycloalkyl, C5-6 cycloalkanone, or a heterocyclic ring system, R7 is hydrogen, C1-6 alkyl, hydroxyC1-6 alkyl, C3-6 cycloalkyl, or a heterocyclic ring system, X is O, S, SO2 or NR8, said R8 being hydrogen or C1-6 alkyl, R9 is hydrogen, C1-6 alkyl, C3-6 cycloalkyl, C1-6 alkyloxy or hydroxy, Y is NR10 or a direct bond, said R10 being hydrogen, or C1-6 alkyl, R11 and R12 each independently are hydrogen, C1-6 alkyl, C3-6 cycloalkyl, or R11 and R12 combined with the nitrogen atom may form an optionally substituted pyrrolidinyl, piperidinyl, piperazinyl or 4-morpholinyl ring. Processes for preparing said products, formulations comprising said products and their use as a medicine are disclosed, in particular for treating conditions which are related to impairment of gastric emptying.
Patent NZ-510516-A (NZ)
Title: Water circulation apparatus for destratifying a body of water
Inventor: ELLIOTT STEPHEN
IPC: E02B1/00
Filed: 1999-08-13
Abstract: A water circulation apparatus for destratifying a body of water such as in a lake or reservoir is disclosed.  Broadly, the apparatus (1) comprises ducting in the form of a draft tube (2) having an upper end (3) positioned towards the surface of the body of water and a lower end (4) positioned towards the bottom of the body of water, and a pump assembly (5) for pumping water through the tube (2).  Broadly, the pump assembly (5) comprises an impeller (20) having six to fourteen blades (21) having a diameter of 3m-5m driven by an electrical motor.  Typically, the apparatus (1) also includes a support in the form of a platform (13) mounted on buoyancy elements (12).  Water enters the draft tube (2) through the upper end thereof and is pumped outwardly through the tube (2) and out through the outlet spaced above the bottom of the body of water.  The apparatus is used to pump water across a thermocline which acts as a barrier to normal convection flow so as to destratify the body of water and to resist the occurrence of a layer of deoxygenated water near the bottom of the body of water.
Patent NZ-511142-A (NZ)
Title: Rainwater tank cleaning system with pipe having closed end and inflow openings near base of tank, to flush out sediment during tank overflow
Inventor: AGNEW WARREN ROY
IPC: E03B3/02
Filed: 2001-04-18
Abstract: A rainwater cleaning system for a water tank comprises a pipe means having a closed end (12) located on the floor of the tank. The pipe means also has an open end connectable to an outflow pipe from the tank. Located nearer the closed end of the pipe rather than the open end of the pipe means is at least one hole (10, 10a). The cross sectional area of the hole preferably at least equals the cross sectional area of the pipe outflow. The pipe means also has an outlet (3) covered with mesh (17) so as to prevent siphoning. Sediment is stated to be cleared from the tank bottom when the tank overflows.
Patent NZ-512162-A (NZ)
Title: Integral package applicator
Inventor: KOPTIS KURTIS J
IPC: B65D47/42
Filed: 1999-11-19
Abstract: A small sized shallow pouch like container (3) for a dispensable ingredient includes a pair of built-in outwardly pivotable flaps (5 & 7) positioned on opposite sides of the container's outlet end to form a package applicator (1). Squeezing the container's sides with the fingers expresses the stored ingredient through the outlet and onto the applicator flaps. Using the container portion as a finger grip, the flaps may be moved about the desired surface, spreading the dispensed ingredient. In some embodiments the outlet is opened by squeezing the container sides to break a closure seal. In others the outlet is unsealed by pulling the flaps apart; by tearing or is unblocked by unfolding the flaps. In a preferred embodiment the container and applicator combination is formed by a pair of flexible foil sheets of substantially identical structure that are superimposed over one another and partially connected together to define both the container and the applicator.
Patent NZ-514764-A (NZ)
Title: Ziprasidone suspension, which is taste-masked and may be used to treat psychosis
Inventor: ARENSON DANIEL RAY
IPC: A61K47/26
Filed: 2000-05-08
Abstract: Ziprasidone has utility as a neuroleptic and is useful, therefore, as an antipsychotic. Described are compositions comprising ziprasidone free base or a difficult to wet pharmaceutically acceptable ziprasidone acid addition salt, a polysorbate, and colloidal silicon dioxide form good aqueous suspensions that have a useful shelf life and are easily re-suspended if settling occurs.
Patent NZ-515310-A (NZ)
Title: Methods of treatment and delivery modes
Inventor: ELLIOTT ROBERT BARTLET
IPC: A61K35/42
Filed: 2001-11-07
Abstract: A biological device capable, upon impaction in a lung capillary of a patient suffering from cystic fibrosis, of treating the patient comprising or including: 1. one or more cells exhibiting substantially normal CFTR production; 2. one or more coatings of a suitable biocompatible material around the one or more cells; 3. one or more proteases associated with the one or more coatings; Wherein the size of the biological device is such that, upon introduction to the venous system of the patient the device will impact substantially in the region of a lung capillary of the patient. And wherein upon impaction, by disruption of the outer surface of the device or otherwise, the one or more proteases are able to act upon a wall of the lung capillary, thereby allowing access (directly or indirectly) of the one or more cells to the lung epithelia. The method of preparing the biological device is also discussed.
Patent NZ-515556-A (NZ)
Title: Purine derivatives, preparation method and pharmaceutical compositions containing same
Inventor: HAESSLEIN JEAN-LUC
IPC: C07D473/16
Filed: 2000-05-18
Abstract: Compounds of formula (I) in all possible isomeric forms and their mixtures, and their salts with acids and bases, their preparation, intermediates for their preparation, and their pharmaceutical use.  The new compounds are of formula (I): Z = -CH2-, -SO2-, -CO-, -COO-, -CONH-, or -(CH2)2-NR3-; n = 0 or 1; R1 = H, aryl, -CH2-aryl, -SO2-aryl, heterocyclyl, -CH2-heterocyclyl, alkyl, or -SO2-alkyl; R2 = alkyl (optionally substituted), saturated or unsaturated cycloalkyl or heterocyclyl with 6 ring members, the heterocyclic atom(s) being O, S, or NR3; Y = O, S, or NR3; D1 and D2 = H, OH, 1-6C alkyl or alkoxy, NHR5; or; together D1 and D2 = =O or =N-OR4; R3 = H, alkyl or cycloalkyl; R4 = H, alkyl, cycloalkyl, or aryl; R5 = H, alkyl, cycloalkyl, or -COOtBu; and R6 = H, halogen, OH, 1-6C alkyl or alkoxy, or NHR3, such that all cycloalkyl, alkyl, aryl and heterocyclyl groups may be substituted by one or more groups selected from halogens, OH, CN, CF3, 1-6C alkoxy, NHR4, COR4, COOR4, CONHR4, aryl and heterocyclyl groups may also be substituted by 1-6C alkyl groups, and all aryl groups may also be substituted by dioxol groups.
Patent NZ-516023-A (NZ)
Title: Blow molded bottle with unframed flex panels
Inventor: OGG RICHARD K
IPC: B65D1/44
Filed: 2000-05-09
Abstract: A hot-fillable, slender, blow-molded plastic bottle (10) for use in containing hot-filled beverages. The bottle has a sidewall (16) with various interactive zones of function. For example, some of the zones are primarily responsible for accommodating vacuum absorption, while other zones are primarily intended to rigidify the container such as by providing post strength to improve container top loading capability. Although each zone may have a primary function, each zone also aids adjacent zones in providing their functions. Thus, the entire sidewall, and not merely selected locations, reacts to the forces generated by the hot-fill process on the container.
Patent NZ-516765-A (NZ)
Title: Topical formulations comprising skin penetration agents and the use thereof
Inventor: ALLAN GEOFFREY
IPC: A61K6/00
Filed: 1999-09-28
Abstract: Disclosed are topical pharmaceutical compositions comprising a pharmaceutically active agent such as a corticosteroid, a diol, cetyl alcohol, glyceryl monostearate, laurocapram, stearyl alcohol, sodium lauryl sulfate and water. Also disclosed is a method for the manufacture of the compositions.
Patent NZ-521533-A (NZ)
Title: Veterinary compositions for the treatment of parasitic diseases containing rafoxanide
Inventor: SHOA A ABDUL RAHMAN
IPC: A61K47/22
Filed: 2001-02-22
Abstract: Micellar non-aqueous or aqueous compositions  for  the therapeutic   treatment  of  animal   diseases   caused   by parasitic  worms  or  nematodes, comprising  rafoxanide  and specific  combinations of solvents which act as  stabilizing and  absorption-promoting agents, wherein the  solvents  are selected  from  non-ionic  surface  active  agents  such  as polyoxyethylene sorbitan monooleate (Tween-80) and  from  N- methylpyrrolidone,  2-pyrrolidone or  dimethylsulfoxide  are disclosed. These  compositions are easy to prepare, stable upon storage and  can  be administered orally, by injection or topically. With  these formulations, an improvement of the efficacy  of rafoxanide in the treatment of the diseases is observed.
Patent NZ-526324-A (NZ)
Title: Novel indanylidene compounds
Inventor: KOCH OSKAR
IPC: C07D319/18
Filed: 2001-10-30
Abstract: Cosmetic compositions for protecting skin and hair, comprising indanylidene compounds of formula (I) useful as UV absorbers.
Patent NZ-527820-A (NZ)
Title: Platelet-specific chimeric immunoglobulin and methods of use therefor
Inventor: COLLER BARRY S
IPC: A61K39/395
Filed: 1994-11-07
Abstract: Described is the use of an immunoglobin or fragment thereof which binds selectively to glycoprotein IIb/IIIa for the manufacture of a medicament for inhibiting stenosis and/or restenosis or for reducing or preventing non-acute ischemic complications of angioplasty. The immunoglobin can inhibit platelet aggregation and also bind selectively to the vitronectin receptor and preferably comprises an antigen binging region derived from the monoclonal antibody 7E3. (62) Divided out of 517475
Patent NZ-532905-A (NZ)
Title: Combinations of peroxisome proliferator-activated receptor (PPAR) activators(s) and sterol absorption inhibitors(s) and treatments for vascular indications
Inventor: KOSOGLOU TEDDY
IPC: A61K45/06
Filed: 2004-05-13
Abstract: The present invention provides compositions and therapeutic combinations including: (a) at least one peroxisome proliferator-activated receptor activator; and (b) at least one substituted azetidinone or substituted b-lactam sterol absorption inhibitor which can be useful for treating vascular conditions, diabetes, obesity and lowering plasma levels of sterols.
Patent NZ-534017-A (NZ)
Title: Support assembly for output shaft of reciprocating power tool
Inventor: MILLION PHIL
IPC: B27B19/00
Filed: 2004-07-09
Abstract: A support assembly 62 for an output shaft 20 of a jigsaw is described. The support assembly 62 includes a support housing 64, a lower bearing 102, and a blade support roller 110 that guides the jigsaw blade 18. A support arm 108 supports the blade support roller 110 and is able to pivot to a small extent relative to the lower bearing 102. This pivoting minimizes the torque applied to the output shaft by reaction forces from the workpiece acting on the blade.
Patent NZ-536926-A (NZ)
Title: Feeding apparatus for products such as fruits
Inventor: VAN WIJNGAARDEN ERIK
IPC: B65G21/20
Filed: 2004-12-01
Abstract: An apparatus for transferring products such as fruit onto, and supplying same to, a conveyor. For instance a rolling conveyor wherein spaces between the rollers and in particular hourglass rollers form nests for a product. Viewed in a conveying direction preceding the conveyor, the apparatus is provided with two flat endless conveyor belts positioned obliquely relative to a vertical plane, continuous in the conveying direction, functioning as a v channel. From a well defined location the endless conveyor belts continue at different angles relative to the conveying direction, with the conveyor belts diverging mutually.
Patent NZ-537778-A (NZ)
Title: Detection of a coronavirus, CRCV, in kennelled dogs with respiratory disease
Inventor: BROWNLIE JOHN
IPC: G01N33/569
Filed: 2003-07-01
Abstract: Described is a canine respiratory coronavirus (CRCV) that is present in the respiratory tract of dogs with canine infectious respiratory disease and that has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (e.g. Quebec and LY138) and human coronavirus strain OC43. The CRCV spike, polymerase and haemagglutinin/esterase cDNA and protein partial sequences are also described.
Patent NZ-540028-A (NZ)
Title: Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
Inventor: ZELDIS JEROME B
IPC: A61K31/454
Filed: 2003-10-24
Abstract: Provided is a method of treating, preventing, modifying or managing pain in a non-human patient, which comprises administering to a non-human patient in need of such treatment, prevention, modification or management a therapeutically or prophylactically effective amount of an immunomodulatory compound selected from: l-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline, and 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline, or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof.
Patent NZ-544977-A (NZ)
Title: Cystatin SN ("CST1") as a marker for detection of gastric cancer
Inventor: GUILFORD PARRY JOHN
IPC: C12Q1/68
Filed: 2004-07-16
Abstract: Disclosed is a method for detecting gastric cancer, comprising: (a) providing a biological sample; and (b) detecting over-expression of a GTM family member in said sample, wherein the GTM family member is cystatin SN ("CSTl").
Patent NZ-547152-A (NZ)
Title: Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
Inventor: FRIEDL THOMAS
IPC: A61K31/55
Filed: 2004-10-05
Abstract: Disclosed is a pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety being a compound of formula (IA) or a tautomer, a pharmaceutically acceptable salt, or solvate thereof, and donepezil or a pharmaceutically acceptable salt, or solvate thereof, and a pharmaceutically acceptable carrier or excipient, and optionally one or more other therapeutic ingredients. Also disclosed is the use of compound (IA) in the manufacture of a medicament for the prevention or treatment of a disease or a disorder, which is selected from the group consisting of pseudodementia, dementia, dementia of Alzheimer Type, Alzheimer's disease, presenile dementia, senile dementia, Lewy-Body-dementia, Down syndrome, fronto temporal dementia, HIV related dementia, Pick's disease, multi-infarct dementia, memory deficits, attention deficits, cognitive dysfunction, memory dysfunction, mild cognitive impairment, age associated memory impairment, ageing-associated cognitive decline, age-related cognitive decline and multiple system atrophy.
Patent NZ-549455-A (NZ)
Title: Air amplifier with centered slot pressure inlet
Inventor: NORRIS HOWARD
Filed: 2006-08-24
Abstract: A fluid amplifier includes a housing 2 in the form of a pipe with an inlet 3 and an outlet 4 for the flow to be amplified. An inlet pipe 5 extends into the interior of the main pipe and has a localised port in the form of a slot 6 which has two parallel side walls substantially longer than two substantially parallel end walls. The flow of air through the main housing 2 is amplified by the air 7 injected into the main pipe via the slot 6.
Patent NZ-552580-A (NZ)
Title: Her2 antibody composition
Inventor: KAO YUNG-HSIANG
IPC: C07K16/32
Filed: 2005-07-15
Abstract: Disclosed is a composition comprising: (a) a main species HER2 antibody that binds to domain II of HER2 and comprises a variable light amino acid sequence provided as SEQ ID NO: 4; and (b) the main species HER2 antibody further comprising an amino-terminal leader extension comprising VHS-, wherein from 5% to about 15% of the antibodies in the composition comprise the amino-terminal leader extension, as quantified by cation exchange analysis.
Patent NZ-552778-A (NZ)
Title: Self-dumping separator with a disc stack
Inventor: WIEKING WOLFGANG
IPC: B04B1/14
Filed: 2005-07-13
Abstract: A self-dumping separator with a vertical axis of rotation is disclosed. The separator includes a drum (1) with solids discharge openings (10), into which a disc stack (3) made up of a plurality of conical discs (4) is inserted. A product to be centrifuged is introduced through an inlet pipe (6) and a distributor (7) in a centrifugal space (2) that is surrounded by the drum (1). At least two or a plurality of fins (17) are arranged in an annular solids space (15) that is arranged radially outside the disc stack (3). The clearance between each of the fins (17) and the inner wall of the drum (1) is at least three millimetres. A splitter disc (23) is arranged in the drum (1) and the diameter of the fins (17) is greater than the diameter of the splitter disc (23) above the disc stack (3) by between 2 mm and 25 mm.
Patent NZ-563057-A (NZ)
Title: Heat treating a biological site in a patient's body
Inventor: PANOS JAMES
Filed: 2007-11-01
Abstract: A system, method and apparatus for a heat treatment device is provided. The device includes: a transformer having a primary winding and a secondary winding, where the secondary winding has at least one tap, to provide a patient reference and at least two sources of radio frequency (RF) energy, the two sources of RF energy being out of phase with each other, and a group of electrodes connected to the sources of RF energy provided by the secondary winding to be simultaneously energised, the arrangement being such that there are more active electrodes connected to one of the sources of RF energy than the other of the sources of RF energy with the energy supplied to one active electrode being out of phase with the energy supplied to an adjacent active electrode.
Patent NZ-563389-A (NZ)
Title: Methods and apparatus for varying the back-up rate for a ventilator
Inventor: BASSIN DAVID JOHN
IPC: A61M16/00
Filed: 2004-03-05
Abstract: An apparatus for providing back up ventilation to a patient comprising: a ventilator adapted to generate and deliver ventilatory support to a patient at a timed rate that is adjustable between a first lower rate and a second higher rate, the first lower rate being significantly lower than the patient's usual respiratory rate and the second higher rate being near the patient's usual respiratory rate; and a controller configured to control the ventilatory support provided by the ventilator for detecting the absence of a spontaneous breath and setting the ventilator to operate initially at the first lower rate, and if after a predetermined time a spontaneous breath has not been detected for setting the ventilator to operate at an increased rate leading up to the second higher rate.
Patent NZ-564732-A (NZ)
Title: Regulation of cytotrophoblast cell differentiation and cell migration
Inventor: ROBERTS CLAIRE
IPC: G01N33/68
Filed: 2002-08-30
Abstract: Disclosed is the use of one or more of IGF-II, a precursor of IGF-II, an isomer of IGF-II, and an analogue of IGF-II in the preparation of a medicament for administration to a female human to prevent and/or treat one or more of implantation failure, recurrent spontaneous miscarriage, pre-eclampsia, intrauterine growth restriction, and placental abruption.
Patent NZ-565829-A (NZ)
Title: Oral contraception with trimegestone at a dose of over 500ug per day and 5 to 55ug ethinyloestradiol
Inventor: GLOGER OLIVER
IPC: A61K31/565
Filed: 2006-07-19
Abstract: Disclosed is a method for contraception comprising administering a contraceptively effective amount of a pharmaceutical composition comprising trimegestone in combination with 5.0 to 55 ìg of ethinyloestradiol to a woman of child-bearing age on at least 21 successive days, beginning on day 1 of the menstrual cycle, wherein the daily dose of trimegestone is more than 500 ìg and is identical on each of the at least 21 successive days. Further disclosed is a solid pharmaceutical composition comprising trimegestone in a quantity of more than 500 ìg in combination with 5.0 to 55 ìg of ethinyloestradiol and further comprising oestradiol.